The BSH Guidelines Official Podcast

In this episode, Dr Charles Percy discusses the joint British Society for Haematology and United Kingdom Haemophilia Centre Doctors' Organisation Guideline on 'Laboratory investigation and clinical management of acquired coagulation factor inhibitors', published in 2025.

Dr Tracey Chan and Dr Dima El-Sharkawi discuss the Updated guidelines for the diagnosis and management of tumour lysis syndrome in adults and children, published in 2025.

Dr Matthew Wilson, Dr Sridhar Chaganti and Dr Wendy Osborne discuss the Clinical management of bispecific antibody therapy for lymphoma Good Practice Paper, published in 2025.

Dr Eyre is a consultant haematologist specialising in lymphoid malignancies in Oxford. 

He has completed an MD Doctorate Thesis in 2017.  He is an investigator on several national lymphoid trials and has published over 170 peer-review articles on lymphoma and CLL.  He is the chair of the low-grade lymphoma clinical trial research group and a core member several lymphoma study groups.  He is a member of the BSH guideline writing groups for various lymphoma subtypes and the lead author for the new ESMO Lymphoma guidelines.  ​He is also an Associate Editor at the British Journal of Haematology.

Podcast recording by James Griffin on the Guideline: Apheresis procedures for the treatment of patients and for the collection of cellular therapy products.